Breaking News
February 21, 2018 - ESRD Death Declines in Vasculitis Patients
February 21, 2018 - Taking ibuprofen for long periods found to alter human testicular physiology
February 21, 2018 - Google AI device could predict a person’s risk of a heart attack
February 20, 2018 - FDA Approves Domestic Source for Tc-99m Isotopes
February 20, 2018 - Sanofi rejects refund demand faces Philippine suit over dengue vaccine (Update)
February 20, 2018 - Researchers discover that activation of specific enzyme may help suppress tumor metastasis
February 20, 2018 - Blood or marrow transplantation survivors have higher risk of cognitive impairment
February 20, 2018 - Booze Beats Pot at Being Unhealthy: Oregon Poll
February 20, 2018 - Morning Break: ’20 Years Late’; Drugs in the Dirt; Catching Flu in the Dorm
February 20, 2018 - Another piece to the puzzle in naked mole rats’ long, cancer-free life
February 20, 2018 - Scientists identify four viruses that can produce insulin-like hormones
February 20, 2018 - New e-Health solution developed to prevent cardiovascular disease, dementia in senior citizens
February 20, 2018 - New genetic risk score could help guide screening decisions for prostate cancer
February 20, 2018 - Study finds higher risk of stroke among blacks with atrial fibrillation than whites
February 20, 2018 - Physical activity could be used as strategy for diabetes prevention
February 20, 2018 - Researchers develop sensing method for early detection of cancer and diabetes
February 20, 2018 - New wearable electronics could be game-changer for stroke rehabilitation
February 20, 2018 - Immune history influences person’s response to flu vaccine
February 20, 2018 - Serenity Now! Learn to Have Patience with Patients
February 20, 2018 - Computer simulation addresses the problem of blood clotting
February 20, 2018 - Women with type 1 diabetes not protected against coronary artery disease
February 20, 2018 - Persistent bloating can be a sign of ovarian cancer, warns charity
February 20, 2018 - Trump administration proposes rule to loosen curbs on short-term health plans
February 20, 2018 - Key protein involved in epigenetic regulation of gene expression guides skin cell renewal
February 20, 2018 - Heart attack symptoms often missed in women
February 20, 2018 - Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms
February 20, 2018 - Study reveals functional dynamics of ion channels
February 20, 2018 - Study explores link between mortality risk and combustible tobacco use
February 20, 2018 - ‘She Trusted Me, and I’d Turned Her Away’
February 20, 2018 - AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies
February 20, 2018 - Fast food makes the immune system more aggressive in the long term
February 20, 2018 - Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s
February 20, 2018 - Overcoming Negative Reviews | Medpage Today
February 20, 2018 - MyD88—villain of allergies and asthma
February 20, 2018 - Food scientists develop rapid screening technique to detect pesticide residue in vegetables
February 20, 2018 - Lab-grown cerebellar cells may help explain how ASD develops at molecular level
February 20, 2018 - Scientists explore connection between bad sleep habits and stiff blood vessels
February 20, 2018 - New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy
February 20, 2018 - Do You Really Need My Signature on That?
February 20, 2018 - HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection
February 20, 2018 - Diabetes does not increase work-loss years due to early retirement
February 20, 2018 - Researchers aim to find out how PTSD affects decisions of police
February 20, 2018 - UH Cleveland Medical Center explores novel treatments for uterine fibroids
February 20, 2018 - Flu Vax Efficacy 25% Against Predominant H3N2 Strain So Far
February 20, 2018 - HIV screening most optimal at 25 years of age if no risk factors
February 20, 2018 - Loyola Medicine primary care physician offers advice to minimize risk of flu
February 20, 2018 - Safe sleep recommendations for parents that may help reduce child’s risk of SUID
February 20, 2018 - Why Do So Few Docs Have Buprenorphine Waivers?
February 20, 2018 - Low levels of alcohol good for the brain
February 20, 2018 - Experimental treatment improves invisible symptoms of a man with spinal cord injury
February 20, 2018 - Myriad’s EndoPredict offers better prediction of breast cancer recurrence, analysis shows
February 20, 2018 - Researchers identify fifteen genes that determine our facial features
February 20, 2018 - Morning Break: New Health IT Player; Luxturna No Bargain; Nuclear Freakout
February 20, 2018 - How does it compare? Hospice care at home, at assisted living facility, at nursing home
February 19, 2018 - Scientists develop water-soluble warped nanographene for bioimaging
February 19, 2018 - It’s Not Your Imagination: You’re Hungrier After Losing Weight
February 19, 2018 - Antihypertensive Use At Delivery Rising in Preeclampsia
February 19, 2018 - A centuries-old math equation used to solve a modern-day genetics challenge
February 19, 2018 - Liquid biopsies could be used as new predictive marker for metastatic TNBC
February 19, 2018 - Russian researchers develop new multi-layered biodegradable scaffolds
February 19, 2018 - Are ‘Vaccine Skeptics’ Responsible for Flu Deaths?
February 19, 2018 - Hidden genetic effects behind immune diseases may be missed, study suggests
February 19, 2018 - Emergency nurses experience regular verbal and physical abuse
February 19, 2018 - Study sheds light on biology that guides behavior across different stages of life
February 19, 2018 - Morning Break: Transgender Breast Feeding; Brazilian ‘Pro-Vaxxers’; Post-Stroke Exercise
February 19, 2018 - Meningitis vaccination strategy in Africa found to be effective, economical
February 19, 2018 - Researchers uncover how excess calcium may influence development of Parkinson’s disease
February 19, 2018 - Psoriasis drug also effective at reducing aortic inflammation
February 19, 2018 - Excess emissions can make serious contributions to air pollution, study shows
February 19, 2018 - Researchers reveal potential biological roots behind individuality
February 19, 2018 - Diabetes Drugs Differ on HF; School-Based Obesity Program Flop; Plaque Type in ACS
February 19, 2018 - Surgical infections linked to drug-resistant bugs, study suggests
February 19, 2018 - Poor awareness may hinder a child’s early dental care
February 19, 2018 - Research finds rising trend in incidence of merkel cell carcinoma
February 19, 2018 - Researchers uncover Ras protein’s role in uncontrolled cancer growth
February 19, 2018 - FDA Approves Apalutamide (Erleada) to Help Curb a Tough-to-Treat Prostate Cancer
February 19, 2018 - Educational Tool Boosts Cervical Length Screening
February 19, 2018 - Spider’s web inspires removable implant that may control type 1 diabetes
February 19, 2018 - Scientists develop fluorescent probe to identify cancer stem cells
February 19, 2018 - University Hospital of Santiago de Compostela participates in large pancreatic cancer study
High-Dose Aspirin Preferred for Kawasaki’s

High-Dose Aspirin Preferred for Kawasaki’s

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study leveraged the differing treatment practices at two hospitals to determine that high-dose aspirin may reduce dependence on IVIG for treatment of Kawasaki disease in children.
  • Be aware that this was not a randomized trial; other treatment practices that differ between the two study hospitals may have influenced the results.

The use of low-dose aspirin in conjunction with a single dose of intravenous immunoglobulin (IVIG) among children with Kawasaki disease was associated with three times the risk of requiring a second IVIG dose compared with high-dose aspirin, a retrospective chart review in two Canadian centers concluded.

In one hospital where low-dose acetylsalicylic acid (ASA; 3 to 5 mg/kg/day) was routinely used, 23% of patients were given a second infusion of IVIG, compared with 8.7% of those treated in another hospital where high-dose ASA (80 to 100 mg/kg/day) was used (P=0.003), according to Anita Dhanrajani, MBBS, of British Columbia Children’s Hospital in Vancouver, and colleagues.

In a multivariable analysis that adjusted for potential confounders including platelet count, age, and C-reactive protein (CRP), the odds ratio for a second IVIG dose with low-dose ASA was 3.2 (95% CI 1.1-9.1, P=0.03), the researchers reported online in Arthritis Care & Research.

Kawasaki disease is an acute vasculitis predominantly affecting children younger than age 5 years, and currently is the most common form of acquired heart disease in developed countries, especially among those of Asian ancestry. The disease is associated with potentially severe cardiac outcomes, particularly the development of coronary artery aneurysms.

The American Heart Association (AHA) first published recommendations for diagnosis and treatment of Kawasaki disease in 1993; these have been revised, most recently in 2017. The recommendations, which favor high-dose aspirin, have been developed to assist clinicians in decision-making regarding treatment with IVIG, ASA, and corticosteroids, but have not been uniformly adopted. While an IVIG dosage of 2 g/kg is standard, the aspirin dose has been varied, with high doses possibly having greater anti-inflammatory effects but low doses being assumed to have better gastrointestinal tolerability.

In addition, IVIG can be costly and should be judiciously used, according to Dhanrajani’s group.

The standard approach used at British Columbia Children’s Hospital (center 1) involves a single IVIG infusion plus aspirin, 3 to 5 mg/kg/day, for 6 weeks, while at Stollery Children’s Hospital in Edmonton (center 2), the aspirin dose is 80 to 100 mg/kg/day until 24 to 48 hours after defervescence.

Some 10% to 20% of children with Kawasaki disease fail to respond to the initial IVIG dose, which is referred to as IVIG resistance. These patients usually are given a second dose, but are at increased risk of coronary complications and may have longer hospital stays and adverse events such as hemolytic anemia.

Therefore, to see if IVIG resistance is influenced by ASA dose, the researchers reviewed 122 charts from the years 2009 to 2014 at center 1 and from 127 at center 2 from 2005 to 2014.

At baseline, patient ages ranged from 33 to 36 months, and almost two-thirds were boys. Asians were significantly more common in center 1 (53.3% versus 13.4%, P<0.001).

The brand of IVIG most often used in center 1 was Gamunex, and a local formulation of 10% IVIG was the most common in center 2.

To determine whether the different time frames in the two centers influenced the results, the researchers conducted a secondary analysis that included patients only seen from 2009 to 2014, finding an incidence of IVIG resistance of 23% in center 1 and 7.3% in center 2.

Among patients requiring a second infusion of IVIG, time between infusions ranged from 25 to 66 hours.

In the main multivariate analysis, ethnicity was not included, because it was assigned based on family name, which can be unreliable because of marriage and mixed ethnicity. However, when Asian ethnicity was added to the analysis, 19.5% of Asian children had IVIG resistance compared with 13.8% of non-Asians, which was not a significant difference, and the odds ratio for low-dose ASA and IVIG resistance was 3.7 (95% CI 1.2-11.6, P=0.02).

The mean hospital stay was 4.1 days in center 1 and 4.7 in center 2. “It is surprising that despite the difference in IVIG resistance, we could not document a difference in length of hospital stay between the two centers. This may be due to differences between the centers in usual practices regarding discharge of patients with Kawasaki disease,” the researchers noted.

Coronary artery aneurysms developed in two patients from center 1 and in six patients from center 2, which was not significantly different. The study was not powered to detect a difference in this outcome, however.

The three times increased odds of a second IVIG dose seen with low-dose ASA represented a 14% absolute increase, and the number needed to treat was seven.

“Until there is better evidence from randomized controlled trials, it seems reasonable to adhere to AHA guidelines and prescribe high-dose ASA in the initial phase of Kawasaki disease,” Dhanrajani’s group concluded.

Among the limitations of the study were its retrospective design and a lack of information about adverse events associated with ASA.

Dhanrajani and co-authors disclosed no relevant relationships with industry.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-04-01T00:00:00-0400

last updated

Tagged with:

About author

Related Articles